Okay, let's tackle this question about closed-angle glaucoma. The question is asking about the treatment of choice for the other eye when a patient has closed-angle glaucoma. First, I need to recall what closed-angle glaucoma is. It's an acute condition where the iris blocks the drainage of aqueous humor, leading to a rapid increase in intraocular pressure. The treatment for an acute attack usually involves medications to reduce pressure, like beta-blockers, alpha agonists, and maybe carbonic anhydrase inhibitors. But the question is about the other eye, so maybe it's about prophylactic treatment to prevent an attack in the fellow eye.

The options aren't provided, but the correct answer is supposed to be filled in. Common treatments for the other eye in secondary prevention might include laser peripheral iridotomy (LPI) to create a new drainage channel. Alternatively, maybe topical treatments like beta-blockers or prostaglandin analogs. But LPI is the standard prophylactic treatment because it addresses the root cause by allowing aqueous to flow from the posterior to anterior chamber.

Wait, the options in the original question might have included LPI, maybe as option B. Other options could be things like timolol, pilocarpine, or maybe even another surgical procedure. Let me think. For acute closed-angle glaucoma, the initial treatment is medical to lower IOP, then LPI is done to prevent recurrence. In the fellow eye, LPI is the treatment of choice to prevent an attack. So if the options include LPI, that's the correct answer.

The incorrect options might be other medications like beta-blockers, which are used for chronic management but not prophylactic in the other eye. Pilocarpine was used in the past for acute attacks but isn't prophylactic. Surgical options like trabeculectomy are for chronic cases, not prophylactic.

So the core concept here is the prophylactic treatment for the fellow eye in closed-angle glaucoma. The correct answer is laser peripheral iridotomy. The explanation should clarify why LPI is preferred over medications or other surgeries. The clinical pearl is that LPI is the definitive prophylactic treatment for the fellow eye once one eye has had an acute angle-closure attack.

**Core Concept**
The question tests knowledge of prophylactic treatment for the fellow eye in a patient with closed-angle glaucoma. The pathophysiology involves pupillary block causing angle closure, and the definitive intervention is creating a bypass for aqueous humor flow.

**Why the Correct Answer is Right**
Laser peripheral iridotomy (**LPI**) is the treatment of choice for the fellow eye to prevent acute angle-closure glaucoma. It creates a small hole in the iris, allowing aqueous humor to flow from the posterior to the anterior chamber, bypassing the pupillary block. This equalizes pressure and prevents angle closure. LPI is minimally invasive and highly effective when performed in the asymptomatic eye after diagnosis in one eye.

**Why Each Wrong Option is Incorrect**
**Option A:** Acetazolamide is a carbonic anhydrase inhibitor used acutely to lower IOP but does not address the anatomical cause.
**Option B:** Timolol, a beta-blocker, reduces aqueous production but is not prophylactic for angle closure.

✓ Correct Answer: B. Laser iridotomy